SCHEMBL26418600

SCHEMBL26418600

Cc1ccc(N2CCC3(CCN(C)CC3)CC2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB1 P08588 1/20 0.50
ALDH1A1 P00352 3/20 0.46
KMT2A Q03164 3/20 0.46
MAPT P10636 2/20 0.46
KDM4E B2RXH2 1/20 0.46
GAA P10253 1/20 0.46
ADRA2C P18825 1/20 0.46
GFER P55789 1/20 0.46
PTK2B Q14289 1/20 0.46
ESR2 Q92731 1/20 0.46
NPC1 O15118 1/20 0.45
RAB9A P51151 1/20 0.45
OPRM1 P35372 2/20 0.45
USP2 O75604 3/20 0.44
CYP2D6 P10635 2/20 0.44
CYP2C9 P11712 3/20 0.44
CYP2C19 P33261 3/20 0.43
CYP1A2 P05177 2/20 0.43
MAPK1 P28482 2/20 0.43
HPGD P15428 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26407559 0.89 ADRB1 (0.43) ADRB1ALDH1A1KMT2ANPC1RAB9A
SCHEMBL24123868 0.87 ADRB1 (0.48) ADRB1ALDH1A1KMT2AMAPTKDM4E
SCHEMBL19832328 0.86 ADRB1 (0.52) ADRB1ALDH1A1KMT2AMAPTKDM4E
SCHEMBL22537876 0.85 ADRB1 (0.50) ADRB1ALDH1A1KMT2AMAPTKDM4E
SCHEMBL12082265 0.84 ADRB1 (0.42) ADRB1ALDH1A1KMT2AUSP2CYP2D6
SCHEMBL12006357 0.83 MAPT (0.69) ALDH1A1KMT2AMAPTKDM4EGAA
SCHEMBL14996510 0.83 TP53 (0.54) ALDH1A1KMT2AMAPTKDM4EGAA
SCHEMBL18053442 0.81 ADRB1 (0.43) ADRB1ALDH1A1KMT2AMAPTNPC1
SCHEMBL26418599 0.81 CYP2D6 (0.69) ADRB1ALDH1A1KMT2AUSP2CYP2D6
SCHEMBL81814 0.81 MAPT (0.65) ADRB1ALDH1A1KMT2AMAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4169919-A1 PYRAZOLO[3,4-D]PYRIMIDINE-3-KETONE DERIVATIVE AS WEE-1 INHIBITOR Wigen Biomedicine Technology (Shanghai) Co., Ltd. (CN) 2023-04-26 EP disclosed